Introduction：Basic information about CAS 955085-14-0|Solanezumab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Solanezumab |
|---|
| CAS Number | 955085-14-0 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Solanezumab BiologicalActivity
| Description | Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1]. |
|---|
| Related Catalog | Research Areas >>Neurological Disease |
|---|
| References | [1]. [1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. N Engl J Med. 2018 Jan 25;378(4):321-330. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
